After a six-month search to find a permanent replacement for research chief John Reed, Sanofi has dipped into the venture capital sector and appointed Houman Ashrafian as its new head of R&D, effective September 11.
Ashrafian is joining the French drugmaker from SV Health Investors, where he is managing partner of the global private equity and venture capital investment platform